RxDoctor Payments Data

Willie Landrum, MD

Hospitalist · Atlanta, GANPI 1760653612

Payments from drug & device makers

$519in general payments, 2019–2025

Across 26 payments — averaging $19.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$338
  • Boehringer Ingelheim$70
  • Gilead$40
  • Melinta Therapeutics, LLC$26
  • Kestra Medical Technology Services, Inc.$24
  • AstraZeneca$22

What the payments were for

  • Food & beverage$519100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$519 in reported general payments places this provider in the 75th percentile of 812 hospitalist providers in Georgia.

See all hospitalist providers in Georgia

Medicare billing

Part B allowed, 2024
$10,259,936
Medicare patients
309
Services billed
6,709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban1,283$224,657
Invega SustennaPaliperidone Palmitate31$100,933
TradjentaLinagliptin275$41,308
JardianceEmpagliflozin213$35,187
XareltoRivaroxaban184$34,503
Trelegy ElliptaFluticasone/Umeclidin/Vilanter67$23,301
Pravastatin Sodium2,273$20,661
Amlodipine Besylate3,544$20,171
EntrestoSacubitril/Valsartan111$20,067
Atorvastatin Calcium2,392$17,624
Levemir FlexpenInsulin Detemir192$15,474
Omeprazole1,677$13,927
NuplazidPimavanserin Tartrate11$13,684
Incruse ElliptaUmeclidinium Bromide35$13,045
VeltassaPatiromer Calcium Sorbitex21$12,774

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta, Jardiance$70$76,495488 claims
AstraZenecaFarxiga$22$6,77436 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 812 hospitalist providers in Georgia.

Other hospitalist in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →